Teladoc Health Inc. (TDOC) stock surged 14.73% during Thursday's trading session, outperforming the broader market.
The telehealth company's shares rallied amid bullish options trading activity, with call option volume significantly higher than normal levels. Additionally, positive analyst commentary from Citron Research boosted investor sentiment towards Teladoc's growth prospects.
According to Citron Research, the market is "sleeping" on Teladoc, and the firm sees the stock rerating higher. The positive outlook stems from Teladoc's recent acquisition of Catapult Health, which is expected to leverage technology to cut costs, improve care, and expand margins.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.